Sanofi risk profile
42 Elevated one input has moved against it
Measured 21 October 2026 from SNY's filed statements. Recomputed nightly.
42 (Elevated), driven by Competitive position at 54, over 5 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 33 | Normal | Stable | Drawdown from the 52-week high — 24.4% |
| Operating pressure | 47 | Elevated | Stable | Operating-margin drift — -6.4 percentage points |
| Cash conversion | 26 | Normal | Stable | Capital spending against operating cash — 0.33x |
| Leverage and coverage | 20 | Normal | Stable | Current ratio — 1.09x |
| Competitive position | 54 | Elevated | Stable | Operating-margin gap against peers — -5.0 percentage points |
| Concentration | Reads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company. | |||
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.